Xiaoban Xin, Ph.D.

Dr. Xiaoban Xin assists companies and research institutes with preparing and prosecuting patent applications, patent portfolio management, strategic patent counseling, and due diligence.
Xiaoban has specific experience working with clients in the fields of biotechnology, including gene editing (e.g., CRISPR technology), next generation sequencing, immunotherapy, cell therapy, biologics, small molecules, stem cells, genetically modified animals, and pharmaceutical formulations.
Xiaoban also has extensive experience in the fields of medical device, chemical engineering and materials, energy and cleantech, mechanical engineering, and health IT.
Prior to practicing law, Xiaoban was a Technology Transfer Fellow at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institute of Health (NIH), where he managed IP portfolios and drafted technology transfer agreements.
Xiaoban received his Ph.D. from The University of Texas Health Science Center and post-doc training at the Johns Hopkins University School of Medicine, where he studied molecular mechanisms underlying diabetes and retinopathy. His research has been published in a number of professional journals.
Xiaoban is fluent in Mandarin Chinese